Carcinoid Heart Disease: Surgical Timing, Right Ventricular Risk Stratification and Operative Strategy
Journal of Cardiovascular Development and Disease · 08.06.2026 · 13 (6) · 254
DOI: 10.3390/jcdd13060254 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 08.06.2026. Verfasst von Hani Ali-Ghosh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Carcinoid heart disease is a progressive right-sided valvulopathy caused by serotonin and other vasoactive mediators released by metastatic neuroendocrine tumours. As oncological therapies have extended survival, cardiac disease has become a leading determinant of mortality. Operative mortality has decreased to 5–6% in contemporary high-volume centres, and long-term survival appears increasingly determined by tumour biology rather than cardiac disease when surgery is appropriately timed. The principal determinant of operative outcome is preoperative right ventricular function; symptom-based referral alone is insufficient because many patients remain compensated until ventricular dysfunction is advanced. This review synthesises the evidence on surgical timing, operative strategy, prosthesis selection, perioperative endocrine management, and emerging transcatheter options. Tricuspid valve replacement is required in the majority of patients, with concomitant pulmonary valve replacement advocated where concurrent disease is present. Bioprosthetic valves are preferred. Continuous perioperative octreotide infusion has substantially reduced the incidence of carcinoid crisis. Structured multidisciplinary decision-making integrating echocardiographic surveillance, biomarker monitoring, and oncological status assessment is essential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK.
ORCID-Profile: Sunil K Ohri
Zitieren
APA
Ali-Ghosh, H., Kho, J., Leventis, F., Asopa, S., Tsang, G., & Ohri, S. K. (2026). Carcinoid Heart Disease: Surgical Timing, Right Ventricular Risk Stratification and Operative Strategy. Journal of Cardiovascular Development and Disease, 13(6), 254. https://doi.org/10.3390/jcdd13060254
Vancouver
Ali-Ghosh H, Kho J, Leventis F, Asopa S, Tsang G, Ohri SK. Carcinoid Heart Disease: Surgical Timing, Right Ventricular Risk Stratification and Operative Strategy. Journal of Cardiovascular Development and Disease. 2026;13(6):254. doi:10.3390/jcdd13060254
BibTeX
@article{AliGhosh2026,
author = {Ali-Ghosh, Hani and Kho, Jason and Leventis, Fotios and Asopa, Sanjay and Tsang, Geoffrey and Ohri, Sunil K},
title = {Carcinoid Heart Disease: Surgical Timing, Right Ventricular Risk Stratification and Operative Strategy},
journal = {Journal of Cardiovascular Development and Disease},
year = {2026},
volume = {13},
number = {6},
pages = {254},
doi = {10.3390/jcdd13060254}
}
EUVIMED